Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
32.34
+3.79 (13.27%)
At close: Aug 14, 2026, 4:00 PM EDT
32.51
+0.16 (0.51%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Faeth Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
29
Market Cap
835.68M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rigel Pharmaceuticals | 276.79M |
| Aclaris Therapeutics | 8.22M |
| DBV Technologies | 5.04M |
| Oculis Holding AG | 1.45M |
| Attovia Therapeutics | 1.35M |
| Silence Therapeutics | 615.00K |
FTH News
- 4 hours ago - Faeth Therapeutics appoints Tiwari, Biegler as Senior Vice Presidents - TheFly
- 2 days ago - Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments - Business Wire
- 8 days ago - Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 9 days ago - Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference - Business Wire
- 12 days ago - Faeth Therapeutics management to meet with BTIG - TheFly
- 12 days ago - Faeth Therapeutics initiated with a Buy at JonesResearch - TheFly
- 12 days ago - Faeth Therapeutics reports Q2 EPS ($2.84) vs ($3.91) last year - TheFly
- 12 days ago - Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates - Business Wire